Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Towers Regulatory News (HTWS)

Share Price Information for Helios Towers (HTWS)

Share Price is delayed by 15 minutes
Get Live Data
223.00    0.40 (0.18%)
Bid:
222.80
Ask:
223.20
Spread: 0.40 (0.18%)
Market Cap: £2.28b
HTWS Live PriceLast checked at - London Stock Exchange

Intraday Helios Towers Share Chart

Helios Towers_TR1_Notification FCA Submitted

15 Sep 2025 14:36

RNS Number : 3846Z
Helios Towers PLC
15 September 2025
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BJVQC708

Issuer Name

HELIOS TOWERS PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of financial instruments

3. Details of person subject to the notification obligation

Name

Helikon Investments Limited

City of registered office (if applicable)

London

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Name

City of registered office

Country of registered office

Helikon Long Short Equity Fund Master ICAV

Dublin

Ireland

5. Date on which the threshold was crossed or reached

28-May-2025

6. Date on which Issuer notified

15-September-2025

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

0.000000

12.074700

12.074700

127448278

Position of previous notification (if applicable)

0.000000

11.068027

11.068027

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

 

Sub Total 8.A

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

Cash Settled Equity Swap

28/02/2035

28/02/2035

Cash

18217463

1.726000

Cash Settled Equity Swap

17/11/2025

17/11/2025

Cash

5767516

0.546400

Cash Settled Equity Swap

16/11/2027

16/11/2027

Cash

44275240

4.194700

Cash Settled Equity Swap

16/11/2027

16/11/2027

Cash

10750367

1.018500

Cash Settled Equity Swap

30/06/2026

30/06/2026

Cash

48437692

4.589100

Sub Total 8.B2

127448278

12.074700%

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Helikon Long Short Equity Fund Master ICAV

Helikon Long Short Equity Fund Master ICAV

12.074700

12.074700%

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

 

12. Date of Completion

29-May-2025

13. Place Of Completion

London

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLUVUORVBUKAAR
Date   Source Headline
18th Mar 202012:02 pmRNSPrice Monitoring Extension
17th Mar 20204:41 pmRNSSecond Price Monitoring Extn
17th Mar 20204:36 pmRNSPrice Monitoring Extension
17th Mar 202012:07 pmRNSSecond Price Monitoring Extn
17th Mar 202012:02 pmRNSPrice Monitoring Extension
13th Mar 202012:07 pmRNSSecond Price Monitoring Extn
13th Mar 202012:02 pmRNSPrice Monitoring Extension
12th Mar 20209:42 amRNSReplacement: Final Results
12th Mar 20207:00 amRNSFinal Results
11th Mar 202012:02 pmRNSPrice Monitoring Extension
9th Mar 20204:38 pmRNSPrice Monitoring Extension
5th Mar 202012:28 pmRNSDirector Declaration
27th Feb 20204:35 pmRNSPrice Monitoring Extension
27th Feb 202012:07 pmRNSSecond Price Monitoring Extn
27th Feb 202012:02 pmRNSPrice Monitoring Extension
19th Feb 20204:10 pmRNSNotice of Full Year Results Date & Conference Call
7th Feb 202012:02 pmRNSPrice Monitoring Extension
13th Jan 20204:16 pmRNSDirector Declaration
10th Jan 202012:08 pmRNSSecond Price Monitoring Extn
10th Jan 202012:02 pmRNSPrice Monitoring Extension
6th Dec 20194:35 pmRNSPrice Monitoring Extension
3rd Dec 20195:13 pmRNSReduction of Capital
22nd Nov 20199:20 amRNSHolding(s) in Company
21st Nov 20198:53 amRNSHolding(s) in Company
20th Nov 201911:15 amRNSDirector/PDMR Shareholding
20th Nov 201911:13 amRNSDirector/PDMR Shareholding
14th Nov 20197:01 amRNSQ3 2019 Results
14th Nov 20197:00 amRNSQ3 Results for Helios Towers Ltd
13th Nov 201912:51 pmRNSHolding(s) in Company
12th Nov 20197:00 amRNSNotice of Q3 Results Date and Conference Call
8th Nov 20199:56 amRNSHolding(s) in Company
5th Nov 20199:22 amRNSHolding(s) in Company
1st Nov 201912:07 pmRNSSecond Price Monitoring Extn
1st Nov 201912:02 pmRNSPrice Monitoring Extension
31st Oct 20195:01 pmRNSExercise of Over-allotment Option
31st Oct 20197:00 amRNSTotal Voting Rights
23rd Oct 20199:02 amRNSHolding(s) in Company
22nd Oct 20195:10 pmRNSHolding(s) in Company
22nd Oct 20192:59 pmRNSHolding(s) in Company
22nd Oct 20199:40 amRNSHolding(s) in Company
22nd Oct 20197:00 amRNSHolding(s) in Company
22nd Oct 20197:00 amRNSHolding(s) in Company
22nd Oct 20197:00 amRNSHolding(s) in Company
22nd Oct 20197:00 amRNSHolding(s) in Company
18th Oct 20198:01 amRNSAdmission to Trading on the London Stock Exchange
15th Oct 20192:07 pmRNSApproval and Publication of Prospectus
15th Oct 20197:00 amRNSPre-stabilisation Period Announcement
15th Oct 20197:00 amRNSAnnouncement of Offer Price

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.